CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

SMS LIFESCIENCES INDIA LTD.

NSE : SMSLIFEBSE : 540679ISIN CODE : INE320X01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE672.351.05 (+0.16 %)
PREV CLOSE () 671.30
OPEN PRICE () 674.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 109
TODAY'S LOW / HIGH ()671.30 688.20
52 WK LOW / HIGH ()464.05 779
NSE674.950 (0 %)
PREV CLOSE() 674.95
OPEN PRICE () 670.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 674.95 (6)
VOLUME 1505
TODAY'S LOW / HIGH() 670.05 692.45
52 WK LOW / HIGH ()472.05 789.9
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 2006

Management Info :

- Chairman TVVSN Murthy - Managing Director

Registered Office :

Address : Plot No 19 – I I I, Road No 71,Opp. Bharatiya Vidya Bhavan Public School,Jubilee Hills,
Hyderabad,
Telangana-500096

Phone : 040-66288888

Website : www.smslife.in

Registrar's Details : Aarthi Consultants Pvt Ltd
1-2-285 ,Domalaguda,,Hyderabad
Listing : BSE, NSE
NEWS
25Apr SMS Lifesciences India informs about d
SMS Lifesciences India has informed that the exchange has received the d..
11Apr SMS Lifesciences India informs about c
SMS Lifesciences India has informed that it enclosed the Certificate rec..
05Apr SMS Lifesciences India informs about d
SMS Lifesciences India has informed that it enclosed is the annual discl..
26Mar SMS Lifesciences India informs about r
SMS Lifesciences India has informed that the exchange has received revis..
26Mar SMS Lifesciences India informs about d
SMS Lifesciences India has informed that the Exchange has received revis..
Financials
in Millions
QTR Dec 23 ANNUAL 23
Net Profit33.15132.18
Gross Profit 50.72 183.73
Operating Profit 96.63292.88
Net Sales 712.273152.42
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Divi's Lab (BSE)
 4025.35 (4.81%)
M.Cap ( in Cr)
106860.39
Sanofi India (BSE)
 8278.10 (1.76%)
M.Cap ( in Cr)
19064.98
Abbott India (BSE)
 25864.85 (0.54%)
M.Cap ( in Cr)
54961.00
Astrazeneca Pharma I (BSE)
 5415.40 (2.18%)
M.Cap ( in Cr)
13538.50
Glaxosmithkline Phar (BSE)
 2132.75 (3.26%)
M.Cap ( in Cr)
36130.07
Shareholding Pattern
PROMOTERS 71.19%
NON-INSTITUTION 28.81%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holding
Scheme NameHold(%)
No Data Found

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX73730.16-609.28 (-0.82%)
NIFTY22419.95-150.40 (-0.67%)
Dow Jones 38085.80-375.12 (-0.98%)
Nasdaq 15611.76-100.99 (-0.64%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI